Literature DB >> 23546714

Fibrinogen.

Linda J Stang1, Lesley G Mitchell.   

Abstract

Fibrinogen is the final essential building block of the clotting process. Thus, all of the preliminary "cause and effect" events in the clotting cascade rely on the work of this molecule to measure their success. The most commonly used laboratory method for measuring fibrinogen is the Clauss fibrinogen assay. The Clauss fibrinogen assay is a quantitative, clot-based, functional assay. The assay measures the ability of fibrinogen to form fibrin clot after being exposed to a high concentration of purified thrombin. Plasma samples are pre-diluted which minimize assay interference from substances like heparin and fibrinogen degradation products. In brief, the diluted plasma is incubated at 37°C prior to the addition of the pre-warmed (37°C) thrombin reagent. From the exact moment of the addition of thrombin, the time to clot is measured. The clotting time in seconds is interpolated from a standard curve made using various dilutions of assayed standard plasma. The following chapter includes detailed information on the Clauss fibrinogen assay. Other fibrinogen assays used include fibrinogen levels derived from prothrombin time assays and antigenic methods. Fibrinogen measurements using the prothrombin time and antigenic based assays are described in brief.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23546714     DOI: 10.1007/978-1-62703-339-8_14

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  5 in total

1.  Reply from the authors.

Authors:  C Solomon; N Rahe-Meyer
Journal:  Br J Anaesth       Date:  2014-06       Impact factor: 9.166

2.  Sex-related differences in the association between plasma fibrinogen and non-calcified or mixed coronary atherosclerotic plaques.

Authors:  Tiewei Li; Fang Wang; Rui Peng; Shengqiang Pei; Zhihui Hou; Bin Lu; Xiangfeng Cong; Xi Chen
Journal:  Biol Sex Differ       Date:  2018-12-05       Impact factor: 5.027

3.  Human Plasma-Derived 3D Cultures Model Breast Cancer Treatment Responses and Predict Clinically Effective Drug Treatment Concentrations.

Authors:  Kristin Calar; Simona Plesselova; Somshuvra Bhattacharya; Megan Jorgensen; Pilar de la Puente
Journal:  Cancers (Basel)       Date:  2020-06-29       Impact factor: 6.639

4.  Evaluation of a potential prognostic parameter for the inflammatory status in COVID-19 patients: The inflammatory protein ratio.

Authors:  Francescopaolo Antonucci; Domenico Di Carlo; Michele Falcone
Journal:  Electrophoresis       Date:  2022-05-19       Impact factor: 3.595

Review 5.  Endothelium, Platelets, and Coagulation Factors as the Three Vital Components for Diagnosing Bleeding Disorders: A Simplified Perspective with Clinical Relevance.

Authors:  Abhinav Bhattarai; Sangam Shah; Sara Bagherieh; Omid Mirmosayyeb; Sangharsha Thapa; Sandip Paudel; Pawan Gyawali; Pitambar Khanal
Journal:  Int J Clin Pract       Date:  2022-08-27       Impact factor: 3.149

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.